Vigilance needed for posaconazole product mis-selection

A new safety concern has emerged in UK pharmacy practice following launch of the gastro-resistant posaconazole powder for oral suspension (Noxafil 300 mg gastro-resistant powder and solvent for oral suspension; Merck Sharp and Dohme). This product, now licensed for paediatric patients from the age o…